Almeida J P, Coletta R D, Silva S D, Agostini M, Vargas P A, Bozzo L, Graner E
Department of Oral Diagnosis, School of Dentistry of Piracicaba, University of Campinas Piracicaba, SP, Brazil.
J Periodontol. 2005 Feb;76(2):272-8. doi: 10.1902/jop.2005.76.2.272.
Fatty acid synthase (FAS) is the enzyme that synthesizes palmitate from malonyl-CoA and acetyl-CoA. Recent studies have shown that FAS is overexpressed in human cancers and that its activity is necessary for cell proliferation. Hereditary gingival fibromatosis (HGF) is a genetic disease manifested as a progressive enlargement of the gingiva. The pathogenesis of this condition is not understood; however, a proliferative advantage of HGF fibroblasts in comparison with cells from normal gingiva (NG) has been described. The aim of this study was to investigate the role of FAS in NG and HGF fibroblast proliferation.
NG and HGF fibroblasts had their proliferative potential assessed by automated cell counting and immunocytochemistry against Ki-67 or proliferating cell nuclear antigen (PCNA). The production of FAS, androgen receptor (AR), and ErbB2 was analyzed by Western blot and the pattern of FAS expression studied by immunocytochemistry. FAS activity was blocked by the specific inhibitor cerulenin.
Higher proliferation rates were found in fibroblasts isolated from HGF than from NG. HGF fibroblasts with greater proliferative potential produced more FAS and AR than the cell lines with lower growth rates, and all studied cell lines produced similar amounts of the ErbB2 protein. In addition, the FAS inhibitor cerulenin was able to significantly reduce the proliferation of both NG and HGF cells.
These results show that FAS is expressed by gingival fibroblasts and that highly proliferative HGF cells produced more FAS and AR than the other fibroblast cell lines. Moreover, FAS inhibition significantly reduced both NG and HGF fibroblast growth, suggesting a role for the androgen-driven fatty acid biosynthesis in their proliferation.
脂肪酸合酶(FAS)是一种将丙二酰辅酶A和乙酰辅酶A合成为棕榈酸的酶。最近的研究表明,FAS在人类癌症中过表达,并且其活性对于细胞增殖是必需的。遗传性牙龈纤维瘤病(HGF)是一种遗传性疾病,表现为牙龈进行性肿大。这种疾病的发病机制尚不清楚;然而,已经描述了HGF成纤维细胞与正常牙龈(NG)细胞相比具有增殖优势。本研究的目的是探讨FAS在NG和HGF成纤维细胞增殖中的作用。
通过自动细胞计数以及针对Ki-67或增殖细胞核抗原(PCNA)的免疫细胞化学方法评估NG和HGF成纤维细胞的增殖潜能。通过蛋白质印迹法分析FAS、雄激素受体(AR)和ErbB2的产生,并通过免疫细胞化学研究FAS的表达模式。FAS活性被特异性抑制剂浅蓝菌素阻断。
从HGF分离的成纤维细胞比从NG分离的成纤维细胞具有更高的增殖率。具有更大增殖潜能的HGF成纤维细胞比生长速率较低的细胞系产生更多的FAS和AR,并且所有研究的细胞系产生的ErbB2蛋白量相似。此外,FAS抑制剂浅蓝菌素能够显著降低NG和HGF细胞的增殖。
这些结果表明牙龈成纤维细胞表达FAS,并且高度增殖的HGF细胞比其他成纤维细胞系产生更多的FAS和AR。此外,FAS抑制显著降低了NG和HGF成纤维细胞的生长,提示雄激素驱动的脂肪酸生物合成在其增殖中起作用。